The purpose of this study is to test the hypothesis: Primary hypothesis: Participants in the dialectical behavior therapy group have greater reductions in the frequency and severity of suicidal and non-suicidal self-injurious behaviors compared to participants in the alternative treatment group. Secondary Hypotheses: Participants in dialectical behavior therapy group have improved treatment outcomes compared to participants in alternative treatment, including mental health service utilization, symptoms of borderline personality and depression symptoms, suicidal thought and hopelessness, disability, and quality of life.
This study will be a 3-year randomized control trial. Patients will be referred from any mental health services in Taipei area who meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria for Borderline Personality Disorder. Inclusion criteria include subjects who fulfill the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria for Borderline Personality Disorder, 18-60 years of age, sign the informed consent, have had at least two episodes of suicidal or non-suicidal self-injurious episodes in the past 5 years, and at least one of which is in the 3 months preceding enrollment. The exclusion criteria include psychotic disorder, bipolar I disorder, severe physical illness, and mental retardation. Outcome measures will be obtained at pre-treatment, 4-month, 8-month and post-treatment (12-month) during 1-year protocol. Using semi-structured interview and a battery of self-report forms, a range of symptoms and behaviors associated with Borderline Personality Disorder will be assessed including suicidal thought, suicide attempt, depression, hopelessness, quality of life, disability, service utilization, and function. Measures are selected based on previous outcome studies of dialectical behavior therapy. Outcome variables will be evaluated by blinded assessors.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
Dialectical behavior therapy (DBT), developed by Marsha Linehan, has gained widespread popularity as a treatment for BPD, and its efficacy has been demonstrated in several trials.
Mackay Memorial Hospital
Taipei, Taiwan
Suicide Attempt Self-Injury Interview (SASII)
change from baseline in Suicide Attempt Self-Injury Interview at 4 months, 8 months and 12 months
Time frame: 4 months, 8 months and 12 months
Borderline Personality Disorder Subscale
Borderline Personality Disorder Subscale (Chinese version) of the Structured Clinical Interview for DSM-IV axis II Personality Disorders ((SCID-II)
Time frame: 4 months, 8 months and 12 months
Borderline Symptom Checklist (BSL-23)
Time frame: 4 months, 8 months and 12 months
The Patient Health Questionnaire (PHQ-9)
Time frame: 4 months, 8 months and 12 months
Symptom Checklist-90-Revised (SCL-90-R)
Time frame: 4 months , 8 months and 12 months
Beck Scale for Suicide Ideation (BSSI)
Time frame: 4 months , 8months and 12 months
Beck Hopelessness Scale (BHS)
Time frame: 4 months, 8 months and 12months
Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q SF)
Time frame: 4 months, 8 months and 12 months
Clinical Global Impressions-Severity (CGI-S) and Improvement (CGI-I)
Time frame: 4 months, 8 months and 12 months
Brief Disability Questionnaire (BDQ)
Time frame: 4 months, 8 months and 12 months
Treatment History Interview (THI)
Time frame: 4 months, 8 months and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.